Laboratorio Reig Jofre SA
FEQ1
Company Profile
Business description
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
Contact
Avenida de les Flors
Sant Joan Despi
Barcelona08970
ESPT: +34 934806710
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,419
Stocks News & Analysis
stocks
The lessons behind the best performing stock over the last 80 years
4 factors that led to the incredible returns of Philip Morris.
stocks
10 of the cheapest global companies with wide moats
These undervalued stocks of high-quality companies could be attractive investments today.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,055.30 | 34.60 | -0.43% |
| CAC 40 | 8,114.57 | 40.59 | 0.50% |
| DAX 40 | 23,380.70 | 226.13 | 0.98% |
| Dow JONES (US) | 41,581.31 | 260.32 | -0.62% |
| FTSE 100 | 8,705.23 | 24.94 | 0.29% |
| HKSE | 24,715.53 | 25.04 | -0.10% |
| NASDAQ | 17,504.12 | 304.55 | -1.71% |
| Nikkei 225 | 37,855.05 | 9.63 | 0.03% |
| NZX 50 Index | 12,045.93 | 30.92 | -0.26% |
| S&P 500 | 5,614.66 | 60.46 | -1.07% |
| S&P/ASX 200 | 7,828.30 | 32.10 | -0.41% |
| SSE Composite Index | 3,423.80 | 5.96 | -0.17% |